Article ID: CBB001320752

A Different Mode of Marketing? The Importance of Scientific Articles in the Marketing Process of Salvarsan (2013)

unapi

Huentelmann, Axel C. (Author)


History and Technology
Volume: 29, no. 2
Issue: 2
Pages: 116-134


Publication Date: 2013
Edition Details: Part of a special issue on the 20th century marketing and advertising of pharmaceuticals.
Language: English

Salvarsan was considered a milestone in bacteriology and pharmacology as a therapeutic against Syphilis. The remedy was introduced into the market in December 1910. In this article, I will analyze this launch which allows investigating a period when drug marketing was in the making. It has been typically linked to branding as a dominant advertising strategy, which turned a particular substance into a well-known product with certain qualities. I want to inquire the role Paul Ehrlich played as the inventor in the launch of Salvarsan; and also, which role scientific articles and clinical reports played in this process. Subsequently, I am going to discuss how the conflicting priorities of public health, ethical reservations, and economic interests were negotiated and how these influenced the factual promotion of Salvarsan. [ABSTRACT FROM PUBLISHER]

...More
Included in

Article Gaudillière, Jean-Paul; Thoms, Ulrike (2013) Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing. History and Technology (pp. 105-115). unapi

Citation URI
https://data.isiscb.org/isis/citation/CBB001320752/

Similar Citations

Article Gaudillière, Jean-Paul; Thoms, Ulrike; (2013)
Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing (/isis/citation/CBB001320751/)

Article Gaudillière, Jean-Paul; (2013)
From Propaganda to Scientific Marketing: Schering, Cortisone, and the Construction of Drug Markets (/isis/citation/CBB001320756/)

Article Hüntelmann, Axel C.; (2010)
Seriality and Standardization in the Production of “606” (/isis/citation/CBB001023534/)

Book Parascandola, John; (2012)
Studies in the History of Modern Pharmacology and Drug Therapy (/isis/citation/CBB001251198/)

Article Ilenia Garoia; (2017)
Farmacista, preparatore, comunicatore, innovatore: il caso Oreste Ruggeri (1857-1912) (/isis/citation/CBB233428609/)

Book Sara E. Black; (2022)
Drugging France: Mind-Altering Medicine in the Long Nineteenth Century (/isis/citation/CBB100452937/)

Book Norman Ohler; (2017)
Blitzed: Drugs in the Third Reich (/isis/citation/CBB528480075/)

Book Kobrak, Christopher; (2002)
National Cultures and International Competition: The Experience of Schering AG, 1851-1950 (/isis/citation/CBB000470819/)

Article Giulia Bovone; (2020)
Bioplastina Serono: il ricostituente preferito dagli italiani (XX secolo) (/isis/citation/CBB350646575/)

Article Greene, Jeremy A.; (2013)
The Materiality of the Brand: Form, Function, and the Pharmaceutical Trademark (/isis/citation/CBB001320757/)

Book Suzanna Reiss; (2014)
We Sell Drugs: The Alchemy of US Empire (/isis/citation/CBB274000980/)

Article CHRISTIAN SAMMER; HANS-GEORG HOFER; (2020)
Projekt V. T.: Paul Martini, Kurt Gutzeit und die „Vergleichende Therapie“, 1939–1949 (/isis/citation/CBB661666911/)

Authors & Contributors
Gaudillière, Jean-Paul
Bovone, Giulia
Thomas, Ulrike
Whiteside, Shaun
Sammer, Christian
Ohler, Norman
Concepts
Pharmaceutical industry
Marketing techniques
Chemical drugs
Therapeutic practice; therapy; treatment
Pharmacy
Pharmacology
Time Periods
20th century, early
19th century
20th century
20th century, late
21st century
Places
Germany
United States
Italy
France
Switzerland
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment